The medtech developer exceeded Wall Street expectations across the board, reporting $19.5 billion in revenue for fiscal year ...

Solventum’s separation from 3M is more than 90% complete following the completion of its planned enterprise resource planning ...

Smith+Nephew’s CEO confirmed this week that talks failed with Johnson & Johnson over an orthopedic megamerger with DePuy ...

Shareholders of Siemens and Siemens Healthineers will vote on the deconsolidation from Siemens during their annual meetings ...

At the TCT conference in San Diego, Medtronic and Recor Medical presented new findings from their rival treatments for high ...

The annual TCT conference in San Diego saw medtechs illustrate methods for controlling stroke, reestablishing coronaries and ...

In the last two quarters, we gained share and our competitive position improved. But we believe that we have reached a ...

The Vitalyst system is a miniature heart pump designed to treat acute myocardial infarction cardiogenic shock.

The study at the TCT conference in San Diego showed Boston Scientific's Watchman FLX Pro could allow for simpler blood ...

Nearly a week after Stryker (NYSE: SYK) reported a tough U.S. health insurance environment for hip and knee procedures, ...

Flow Medical expects a first-in-human case "very soon" and an IDE submission in 2027, co-founder and CEO Jennifer Fried tells ...

The trial found earlier interventions with Edwards’ Sapien 3 TAVR implant brought fewer heart failure-related events after two years.